Author:
Behrsing Holger Peter,Furniss Michael J.,Robillard Kristine A.,Tomaszewski Joseph E.,Parchment Ralph E.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference51 articles.
1. Adams DM, Zhou T, Berg SL, Bernstein M, Neville K, Blaney SM (2008) Phase 1 trial of O6-benzylguanine and BCNU in children with CNS tumors: a Children’s Oncology Group study. Pediatr Blood Cancer 50:549–553
2. Aida T, Cheitlin RA, Bodell WJ (1987) Inhibition of O6-alkylguanine-DNA-alkyltransferase activity potentiates cytotoxicity and induction of SCEs in human glioma cells resistant to 1, 3-bis(2-chloroethyl)-1-nitrosourea. Carcinogenesis 8:1219–1223
3. Cussac C, Rapp M, Mounetou E, Madelmont JC, Maurizis JC, Godeneche D, Dupuy JM, Sauzieres J, Baudry JP, Veyre A (1994) Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes. J Pharmacol Exp Ther 271:1353–1358
4. Dolan ME, Corsico CD, Pegg AE (1985) Exposure of HeLa cells to 0(6)-alkylguanines increases sensitivity to the cytotoxic effects of alkylating agents. Biochem Biophys Res Commun 132:178–185
5. Dolan ME, Larkin GL, English HF, Pegg AE (1989) Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine. Cancer Chemother Pharmacol 25:103–108
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献